Stril

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Stril

What is Stril?

Stril is a pharmaceutical medication containing the active substance lisinopril. It belongs to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. These medications are primarily utilized to manage conditions related to the cardiovascular system and kidney function.

Mechanism of Action

Stril works by inhibiting the activity of the angiotensin-converting enzyme. This enzyme is responsible for the production of angiotensin II, a potent chemical in the body that causes blood vessels to tighten and narrow. By reducing the production of angiotensin II, Stril allows blood vessels to relax and widen. This process helps to lower blood pressure and reduces the workload on the heart, making it easier for the heart to pump blood throughout the body.

Therapeutic Applications

Stril is used in several clinical contexts to manage chronic health conditions:

  • Hypertension: It is frequently used to treat high blood pressure, helping to maintain levels within a target range.
  • Heart Failure: It may be used as part of a management plan for heart failure, where the heart is unable to pump blood as effectively as it should.
  • Post-Myocardial Infarction: Following a heart attack, Stril may be administered to help improve survival rates and reduce the risk of further heart complications.
  • Diabetic Nephropathy: In individuals with diabetes and high blood pressure, it is sometimes used to help protect kidney function and slow the progression of kidney disease.

Characteristics

As an ACE inhibitor, Stril is typically used for long-term management rather than acute, immediate relief. Its effects on blood pressure and heart function are gradual, and it is often integrated into a broader therapeutic strategy that may include lifestyle adjustments and other medications.

Regulatory References

  1. Lisinopril: MedlinePlus Drug Information

What side effects are possible with Stril?

Possible side effects and safety information

Adverse Reaction Profile

The safety profile for Stril is based on data collected during clinical trials and post-marketing surveillance. Adverse reactions are systematically documented and classified by System Organ Class (SOC) and frequency according to regulatory standards (e.g., Very Common: 1/10; Common: 1/100 to < 1/10).

Commonly documented adverse reactions typically involve the Gastrointestinal, Nervous System, and Skin SOCs, which may include mild and transient effects like nausea, headache, or localized skin reactions.

Adverse Reaction Type Classification Examples
Serious Reactions Events resulting in death, life-threatening conditions, hospitalization, or persistent disability, such as severe hepatic injury or hypersensitivity reactions.
Clinically Significant Effects like angioedema, new-onset depression, or specific changes in lab parameters (e.g., renal function markers).

Safety Restrictions and Monitoring

Safety documents specify contraindications, which are conditions where the medication must not be used due to high risk. Additionally, special warnings and precautions highlight situations requiring careful monitoring.

Specific safety considerations are noted for vulnerable populations, including patients with pre-existing hepatic or renal impairment, and are often detailed by dose- or exposure-related risk patterns (e.g., increased risk of certain toxicities with prolonged therapy or at higher doses).

High-level monitoring described in official documents requires periodic assessment of key laboratory parameters, such as blood cell counts and liver or kidney function tests, to detect potential toxicities early. Patients are formally advised that the risk-benefit profile is subject to continuous review by regulatory authorities.

Overdose and Emergency Response

The principal clinical consequence of Stril (Lisinopril) overdosage is the expected exaggerated pharmacological effect, centered on severe hypotension (extremely low blood pressure). This presentation can manifest as lightheadedness or fainting (syncope), and regulatory documents recognize the potential for unmanaged hypotension to progress to circulatory shock, a severe and life-threatening outcome. Additional documented risks involve acute renal failure and the electrolyte abnormality hyperkalemia (elevated serum potassium levels).

In all suspected cases of Stril overdosage, immediate medical attention must be sought. If a person has collapsed, had a seizure, or is unresponsive, emergency services must be contacted without delay. The official management is symptomatic and supportive, as no specific antidote is known for Lisinopril. The established procedural steps for severe hypotension include placing the patient in the supine position and initiating the intravenous infusion of normal saline to restore volume and blood pressure. Continuous monitoring for electrolytes and renal function is required. Official data confirms that Lisinopril is removable from the circulation by hemodialysis in situations where rapid clearance is required.

Therapeutic Uses of Stril

Stril (Lisinopril) is a therapeutic agent used for the long-term management of conditions marked by increased physiological stress on the circulatory system, applied across therapeutic domains where additional symptomatic support is needed. The medication generally assists with maintaining functional stability in chronic illness.

The medicine plays a role in managing conditions associated with acute or disruptive episodes, including essential hypertension, Heart Failure (with reduced ejection fraction), care after an Acute Myocardial Infarction, and specialized support for Diabetic Nephropathy.

In these scenarios, Stril provides supportive relief that helps ease the overall symptom burden. It is generally used to help with reducing the likelihood of severe episodes and supports general well-being during symptomatic phases. This management generally contributes to easing the risks associated with long-term organ-specific functional stress, particularly by helping to manage symptoms related to fluid and volume overload and blood pressure lowering.

Quick Fact: Support for Fluid Imbalance
Stril assists with managing symptom clusters that may become disruptive, such as peripheral swelling (edema) and shortness of breath associated with fluid imbalance in heart failure.

Eligibility and Restrictions for Use

Who Can and Cannot Use Stril?

Stril (active ingredient: Rilonacept) is an interleukin-1 (IL-1) blocker used to treat certain autoinflammatory conditions, primarily Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS). Its use is determined by the specific diagnosis and a patient's medical history.


Typical Indications (Who Can Use Stril)

Stril is approved for patients, typically adults and children aged 12 and older, diagnosed with:

  • Cryopyrin-Associated Periodic Syndromes (CAPS): Specifically FCAS and MWS.
  • Deficiency of IL-1 Receptor Antagonist (DIRA): Also known as Chronic Recurrent Multifocal Osteomyelitis (CRMO) associated with DIRA mutation (in some regions).

Contraindications (Who Should Not Use Stril)

Stril should not be used in individuals with:

  • Known Hypersensitivity: A previous severe allergic reaction to rilonacept or any component of the formulation.
  • Active, Serious Infection: Treatment initiation should be delayed until the infection is controlled, due to the drug's immunosuppressive effects.
  • Active Malignancy: Use should be considered cautiously and discussed thoroughly with a specialist, as the effect on malignancy progression is not fully understood.

Patients should also be screened for latent tuberculosis (TB) before starting treatment, as the drug can increase the risk of TB reactivation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Stril (modeled after the combination product Stribild) has a complex interaction profile, primarily due to its component that acts as a strong inhibitor of the CYP3A enzyme system and a substrate for various transporters. Co-administration with certain products can significantly alter the levels of Stril or the co-administered drug, potentially leading to reduced effectiveness or increased side effects.

Contraindicated Combinations

Co-administration with several specific drug classes and products is contraindicated and should be strictly avoided. These include certain narrow therapeutic index medications, strong CYP3A inducers like Rifampin and St. John’s wort, and several anti-epileptics such as Carbamazepine and Phenytoin. Combining these may lead to a dangerous decrease in Stril levels, resulting in loss of therapeutic effect.

Required Monitoring and Dosage Adjustments

Caution and clinical monitoring are mandatory when Stril is co-administered with certain other medicines. These interactions require close follow-up or dosage adjustments for the co-administered drug. Examples include some heart medications (Digoxin), anti-coagulants (Warfarin), and specific statins (Lovastatin or Simvastatin). For products like certain antacids, a timing-based separation of at least two hours is required to prevent reduced absorption of Stril. Patients must inform their healthcare provider of all prescription, over-the-counter, and herbal products currently being taken.

Mechanism of Action

How Stril Works: Unraveling Its Mechanism of Action

Stril acts within cellular domains involving receptor-mediated signaling, specifically as an allosteric modulator. This binding occurs at a site distinct from the primary ligand site, which modifies the receptor's affinity and alters its conformational state. This molecular engagement initiates or suppresses specific signaling sequences that influence targeted intracellular pathways.

The mechanism proceeds by modifying early molecular steps in cascades associated with heightened physiological responses. Stril affects the magnitude of downstream signal propagation by influencing feedback regulation within these pathways, thereby influencing the homeostasis of the targeted biological systems.

Ultimately, Stril engages mechanisms that reduce the signaling intensity resulting from excessive mediator activity and subsequent cellular effects. This molecular action results in modifications to downstream physiological parameters by modifying pathway activity that influences specific signaling patterns.

Dosage and Administration Information

Stril (Lisinopril) is administered orally in a once-daily regimen, a frequency pattern established across all approved uses. The tablets or oral solution must be taken at approximately the same time each day, and intake is independent of meals, meaning it can be taken with or without food.

Official Dosing Framework

Administration begins with a low starting dose that is gradually adjusted upward (titrated) based on the official labeled schedule, which dictates dose increases occur no more frequently than one to four weeks depending on the indication. The standard regimens are as follows:

  • Hypertension (Adults): The usual starting dose is 10 mg once daily, though a lower 5 mg dose is used when the patient is concurrently taking a diuretic. The typical maintenance range is 20 mg to 40 mg once daily, with a labeled maximum dose of 80 mg.
  • Heart Failure: The initial dose is 5 mg once daily, or 2.5 mg for patients with low serum sodium (less than or equal to 130 mEq/L). The maximum recommended daily dose for this use is 40 mg.
  • Acute Myocardial Infarction (AMI): A minimum six-week course is prescribed, beginning with 5 mg within the first 24 hours, followed by a scheduled step-up to a maintenance dose of 10 mg once daily.

Special Procedural Conditions

Dosage modification is mandatory for specific populations and circumstances. For patients with impaired renal function (Creatinine Clearance < 30 mL/min), the initial dose must be halved (e.g., 5 mg or 2.5 mg starting dose). In pediatric patients (greater than or equal to 6 years), dosing is based on body weight, starting at 0.07 mg/kg and not to exceed a 5 mg initial dose or 40 mg daily maximum. If a dose is missed, it should be taken as soon as possible, unless it is close to the next scheduled time, in which case the missed dose is skipped.

Recent Clinical Evidence

Research evidence / Overview of studies for Stril (Lisinopril)


Evidence for use in Essential Hypertension (High Blood Pressure)

Research for Stril's evaluation in managing high blood pressure includes large-scale, long-term Randomized Controlled Trials (RCTs) and comparative studies. These studies were used in research exploring how blood pressure changes over time, as well as examining long-term outcomes related to systemic or functional imbalance. Researchers monitored how blood pressure readings changed and how outcomes related to major events like stroke or heart attack were tracked over many years.

Studies monitored differences in blood pressure response in Black patients when the medicine was used alone, which was observed in the research. While long-term data for major outcomes are available, findings were mixed or less extensive for certain smaller subgroups within the trials.


Evidence for use in Heart Failure

Stril was evaluated in large, long-term, placebo-controlled RCTs for its evaluation in conditions marked by functional limitations, typically when used alongside other standard heart failure medicines. Research examined outcomes related to systemic or functional imbalance, such as hospitalization rates and mortality tracking. Studies focused on episodes where symptoms become more noticeable, particularly in patients with chronic heart failure showing evidence of reduced heart function.

Uncertainty remains regarding dosing. Research comparing high versus low doses of Stril reported that while some measured combined outcomes differed, differences in all-cause mortality were not always statistically significant between the dose groups. The evidence is largely derived from settings with varying symptom burdens, as the patients studied were typically already stabilized and receiving other standard treatments, meaning results apply specifically to that context.


Evidence for use following Acute Myocardial Infarction

Stril was studied for use in conditions associated with acute or disruptive episodes, specifically when treatment started shortly after a heart attack, usually within the first 24 hours. These large-scale, randomized trials measured key outcomes such as the tracking of 30-day and long-term mortality and the incidence of nonfatal cardiac failure.

Studies monitored whether the prompt use of Stril after a heart attack was associated with tracked differences in the proportion of patients surviving past 30 days compared to control groups. The trials generally did not include patients who were severely unstable, such as those with very low blood pressure or cardiogenic shock, and therefore, the findings apply mostly to the studied populations who were stable at the time of enrollment.

Frequently Asked Questions (FAQ)

Common questions about Stril (FAQ)


Q: How quickly does Stril start working?

The blood pressure lowering effect of Stril generally starts within about 2 hours after a dose is taken, with the maximum effect usually occurring around 6 hours. However, official product information indicates that it may take between 2 to 4 weeks to see the full therapeutic benefit.


Q: How long do the effects of Stril last?

According to official product information, the effect of Stril to lower blood pressure is typically maintained for at least 24 hours. This duration supports the standard once-daily dosing regimen. The effective accumulation half-life—a measure of how long the drug remains in the system—is approximately 12 hours.


Q: Are there any specific foods or drinks to avoid while taking Stril?

Regulatory documents state that Stril can be taken with or without food as the presence of food does not affect its absorption. Regulatory documents indicate that co-administering Stril with alcohol may increase the blood pressure-lowering effect, potentially leading to dizziness or fainting.


Q: Does Stril interact with birth control pills?

Official information does not specifically list an interaction with hormonal contraceptives, or birth control pills. The label focuses on interactions with other classes of medicines like antidiabetics, non-steroidal anti-inflammatory drugs (NSAIDs), and other blood pressure medications that require monitoring.


Q: Does Stril have a risk of dependence or withdrawal?

Stril (Lisinopril) is not classified as a controlled substance by regulatory bodies like the U.S. DEA, meaning it is not associated with typical dependence risk. However, stopping treatment abruptly is not recommended and may cause blood pressure to rapidly increase (rebound hypertension).


Q: Can Stril affect my ability to drive or operate machinery?

The official warning sections note that Stril can cause side effects such as dizziness, lightheadedness, or fainting. Official warnings state that patients should be cautious about driving or operating machinery until they know how the medication affects them.


Q: Has Stril been studied in pregnant patients?

Studies and official information indicate that Stril is generally contraindicated during pregnancy, especially during the later stages. This is because medications that affect the Renin-Angiotensin System, the pathway Stril targets, have been shown to cause injury or death to the developing fetus.


Q: Is Stril available as a generic medicine?

Yes, regulatory records, such as the FDA’s Approved Drug Products list, indicate that generic versions of Stril (lisinopril) are available in the market for various strengths and dosage forms.


Q: What happens if I accidentally take more Stril than prescribed?

According to the official overdose information, taking more Stril than prescribed may result in severely low blood pressure (hypotension), which is the most likely symptom. It may also lead to symptoms related to kidney or liver issues. In the event of an overdose, contacting emergency services or seeking immediate medical attention is required.


Q: Does Stril interact with alcohol?

The official safety documents indicate that alcohol can enhance the blood pressure-lowering effect of Stril. This combination increases the risk of the patient's blood pressure dropping too low, which can cause dizziness. Official documents describe the risk that alcohol consumption may increase the hypotensive effect of the drug.


Q: How is Stril eliminated from the body?

Official product information states that Stril is an active drug that is not metabolized in the body. Instead, it is excreted in its unchanged form, almost entirely through the kidneys in the urine.


Q: Can Stril cause problems with sleep?

While the drug's adverse reaction profile does not typically list sleep disruption as a common direct effect, it does list side effects such as headache, cough, and dizziness that could indirectly interfere with sleep. Other drugs in the same class may also list sleep disturbances.


Q: What are the most common reasons patients stop taking Stril?

Data from clinical trials indicates that the most common adverse effects that led patients to discontinue treatment were cough and dizziness. However, regulatory studies show that only a small percentage of patients needed to stop treatment due to these or other side effects.


Q: Does taking Stril affect fertility?

Nonclinical animal studies on the drug class generally found no evidence of reproductive toxicity or adverse effects on fertility. The regulatory focus on reproduction is primarily related to use during pregnancy.


Q: Can Stril be used in older adults?

Yes, Stril is indicated for use in older adults, and dosage modification is not required based on age alone. However, official information notes that monitoring of kidney function is often required for this population to help prevent issues like low blood pressure or renal dysfunction.


Q: What is the regulatory status of Stril (e.g., approved, pending)?

Stril (Lisinopril) is a fully approved and established prescription pharmaceutical agent. It has been reviewed and licensed for its approved uses by major regulatory bodies worldwide, including the U.S. Food and Drug Administration (FDA).


Q: Can Stril cause changes in weight?

Official clinical studies generally do not indicate a measurable direct effect of the drug on body weight. However, certain serious, but rare, adverse events such as severe swelling (angioedema) or fluid retention can result in apparent weight changes.


Q: What should I do if a specific mild side effect from Stril doesn't go away?

If a common, mild side effect like a cough, headache, or stomach upset persists for more than a few days, or if the side effect becomes severe, consultation with a healthcare provider for evaluation is generally advised.


Q: Is Stril generally considered a long-term medicine?

Yes, official documents outlining the drug’s purpose and indications state that Stril is typically prescribed for the long-term management of conditions such as high blood pressure and heart failure.


Q: Can Stril be taken with common over-the-counter pain relievers?

Regulatory documents indicate that taking Stril with non-steroidal anti-inflammatory drugs (NSAIDs), such as certain OTC pain relievers, may lead to a deterioration of kidney function. Monitoring of renal function is recommended if this combination is used, especially in the elderly.


Q: How long does it usually take for common side effects of Stril to resolve?

The adverse reaction profile describes common side effects as mild and transient. This means they are usually expected to resolve or lessen in intensity within a few days or weeks of starting the treatment, but patients should report any persistent issues.


Q: Can I stop taking Stril if I feel better?

Official warnings describe that stopping Stril suddenly without guidance from a healthcare professional is not recommended. Abrupt discontinuation can lead to a rapid and dangerous increase in blood pressure (known as rebound hypertension).

How should Stril be stored and disposed of?

How to Store and Dispose of Stril?

The official guidance for Stril (Lisinopril) storage and disposal is based strictly on maintaining the tablet's integrity and ensuring environmental safety.


Storage Requirements

Stril must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). To maintain stability, the medication must be protected from moisture and must not be frozen. It is mandatory to keep Stril in its original closed container until use.


Disposal and Safety

All medicines must be kept out of the sight and reach of children. Any unused or expired Stril should not be kept. For disposal, follow local pharmaceutical waste regulations, such as utilizing an authorized drug take-back program. Do not dispose of Stril by flushing it down a toilet or pouring it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Stril found in:

A-Z Index: